SE7704928L - Desaminoderivat av kallikrein-trypsin-inhibitor, sett for framstellningen derav samt anvendning derav som lekemedel - Google Patents

Desaminoderivat av kallikrein-trypsin-inhibitor, sett for framstellningen derav samt anvendning derav som lekemedel

Info

Publication number
SE7704928L
SE7704928L SE7704928A SE7704928A SE7704928L SE 7704928 L SE7704928 L SE 7704928L SE 7704928 A SE7704928 A SE 7704928A SE 7704928 A SE7704928 A SE 7704928A SE 7704928 L SE7704928 L SE 7704928L
Authority
SE
Sweden
Prior art keywords
kallikrein
trypsin inhibitor
medicines
preparation
residues
Prior art date
Application number
SE7704928A
Other languages
English (en)
Other versions
SE442301B (sv
Inventor
E Schnabel
H D Schlumberger
G Reinhardt
E Truscheit
H Tschesche
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of SE7704928L publication Critical patent/SE7704928L/sv
Publication of SE442301B publication Critical patent/SE442301B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114Kunitz type inhibitors
    • C07K14/8117Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/26Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SE7704928A 1976-04-30 1977-04-28 Sett att framstella deaminoderivat av kallikrein-trypsin-inhibitor fran notorgan SE442301B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762619246 DE2619246A1 (de) 1976-04-30 1976-04-30 Desamino-derivate des kallikrein- trypsin-inhibitors, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel

Publications (2)

Publication Number Publication Date
SE7704928L true SE7704928L (sv) 1977-10-31
SE442301B SE442301B (sv) 1985-12-16

Family

ID=5976820

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7704928A SE442301B (sv) 1976-04-30 1977-04-28 Sett att framstella deaminoderivat av kallikrein-trypsin-inhibitor fran notorgan

Country Status (11)

Country Link
US (1) US4118481A (sv)
JP (1) JPS52134009A (sv)
AT (1) AT361118B (sv)
BE (1) BE854102A (sv)
CH (1) CH635514A5 (sv)
DE (1) DE2619246A1 (sv)
DK (1) DK188077A (sv)
FR (1) FR2349598A1 (sv)
GB (1) GB1533358A (sv)
NL (1) NL7704690A (sv)
SE (1) SE442301B (sv)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748294A1 (de) * 1977-10-27 1979-05-03 Bayer Ag Neue derivate des bpti, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2748295A1 (de) * 1977-10-27 1979-05-03 Bayer Ag Neue derivate des bpti
US5665216A (en) * 1986-10-21 1997-09-09 Northeastern University Capillary column for high performance electrophoretic separation and detection of SDS proteins and system and using the same
US4997537A (en) * 1986-10-21 1991-03-05 Northeastern University High performance microcapillary gel electrophoresis
ATE275583T1 (de) * 1994-01-11 2004-09-15 Dyax Corp KALLIKREINHEMMENDE ßKUNITZ-DOMÄNEß-PROTEINE UND DERIVATEN DAVON
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
ATE277081T1 (de) * 1994-01-11 2004-10-15 Dyax Corp Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
US20040054082A1 (en) * 2001-12-03 2004-03-18 Bank David H Toughened polymer blends with improved surface properties
US7153829B2 (en) * 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
ATE528014T1 (de) * 2002-06-07 2011-10-15 Dyax Corp Polypeptid mit modifizierten kunitz domains
SI2386310T1 (sl) 2002-08-28 2019-03-29 Dyax Corp. Metode za ohranjanje organov in tkiv
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
US7276480B1 (en) 2005-12-30 2007-10-02 Dyax Corp. Prevention and reduction of blood loss
WO2007106746A2 (en) * 2006-03-10 2007-09-20 Dyax Corp. Formulations for ecallantide
AU2008289005A1 (en) * 2007-08-21 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
WO2009026539A1 (en) * 2007-08-23 2009-02-26 Genzyme Corporation Treatment with kallikrein inhibitors
WO2010080833A1 (en) * 2009-01-06 2010-07-15 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
HUE057244T2 (hu) 2010-01-06 2022-04-28 Takeda Pharmaceuticals Co Plazma kallikreint kötõ fehérjék
JP2014506257A (ja) 2011-01-06 2014-03-13 ダイアックス コーポレーション 血漿カリクレイン結合タンパク質
JP6719384B2 (ja) 2014-03-27 2020-07-15 ダイアックス コーポレーション 糖尿病黄斑浮腫の治療のための組成物および方法
US11286307B2 (en) 2015-12-11 2022-03-29 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack

Also Published As

Publication number Publication date
FR2349598A1 (fr) 1977-11-25
GB1533358A (en) 1978-11-22
ATA305477A (de) 1980-07-15
FR2349598B1 (sv) 1980-02-22
DK188077A (da) 1977-10-31
AT361118B (de) 1981-02-25
DE2619246A1 (de) 1977-11-10
CH635514A5 (de) 1983-04-15
JPS52134009A (en) 1977-11-09
BE854102A (fr) 1977-10-31
US4118481A (en) 1978-10-03
SE442301B (sv) 1985-12-16
NL7704690A (nl) 1977-11-01

Similar Documents

Publication Publication Date Title
SE7704928L (sv) Desaminoderivat av kallikrein-trypsin-inhibitor, sett for framstellningen derav samt anvendning derav som lekemedel
BR9707010A (pt) Derivados de aminoácidos sulfonados e inibidores de metalproteinase contendo os mesmos
ES464571A1 (es) Procedimiento para la obtencion de derivados del inhibidor de tripsina-calicreina.
OA01267A (fr) Obtention d'aminoacides du type L-alpha-alkyl-bêta-(3,4-dihydroxyphényl) alanine.
AR010339A1 (es) Derivado de benzamida heterociclica sustituida y su uso
DK0675717T3 (da) Anvendelse af 2-amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) som lægemiddel med antidepressiv virknin
DK107077A (da) 4,5-dichlorimidazol-2-carboxylsyrederivater, fremgangsmade til deres fremstilling samt deres anvendelse som skadedyrsbekempelsesmidler
SE7707339L (sv) Dipeptidderivat och forfarande
FI793261A (fi) Farmaceutisk komposition som innehaoller 3,4-dihydro-3-oxo-2-kinoxaliner
SE7707129L (sv) Dipeptider
FI823165L (fi) -laktamas inhibiterande 2- -substituerade-2- metyl(5r) penam-3- -karboxylsyra-1,1-dioxider och deras mellanprodukter
DK159450C (da) 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin b og farmaceutisk acceptable syreadditionssalte deraf samt 9-deoxo-9a-aza-9a-homoerythromycin b til anvendelse som mellemprodukt ved fremstilling deraf
AR223015A1 (es) Procedimiento para la preparacion de nuevos derivados de 4-amino-2-(4-(1,4(5)-benzodioxaciclohexil(heptil)-2-carbonil)-piperazin-1-il)quinazolina y sus sales de adicion de acidos farmaceuticamente aceptables
SE7609971L (sv) N-(1,2,4-triazin-5-on-4-yl)-glycin-derivat, till anvendning som herbicider och sett for deras framstellning
ATE18043T1 (de) 2-phenyl-morpholin-derivate und arzneimittel.
NO147588C (no) Fremgangsmaate for tildanning av en sproeytestoept foring i et ventilhus.
ES474559A1 (es) Procedimiento para la obtencion de derivados del inhibidor de tripsina pancreatica basica
JPS5692261A (en) Novel cyclohexanecarboxylic derivative and its preparation
SE8002244L (sv) Nytt 1alfa,25-dihydroxi-cholekalciferolderivat, sett for framstellning samt anvendning derav som lekemedel och farmaceutiska kompositioner inehallande denna forening
JPS5235227A (en) Preparation of filters for adhesives
JPS5692260A (en) Cyclohexanecarboxylic ester and its preparation
USD130810S (en) Design for a lighting fixture
ES378209A2 (es) Procedimiento para la preparacion de nuevos 2- amino - 5 - nitro - triazoles sustituido en el grupo amino.
JPS5252691A (en) Method of determining activity value of leucin amino eptidase
DK477378A (da) Derivater af bpti (("basic pancreatic trypsininhibitor"), fremgangsmaade til fremstilling deraf samt disses anvendelse som laegemidler

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7704928-6

Effective date: 19880822

Format of ref document f/p: F